Two Different Circuits, Two Different Drugs
One drug quiets a single wake switch, the other dampens the whole brain.
- 2: Orexin receptors (OX1R and OX2R only)
- 19: GABA-A subunit genes (assembled combinatorially)
- ~70,000: Orexin neurons (LH) (a small, specific pool)
- ~40%: GABA-A synapses (of all brain synapses)
Orexin antagonists block one wake signal
They occupy OX1R/OX2R, muting arousal neurons directly.
Benzodiazepines amplify GABA everywhere
They bind GABA-A receptors distributed across nearly the whole brain.
Z-drugs share the benzodiazepine target
Z-drugs hit the same GABA-A site, just more selectively.
Tolerance, Withdrawal, and Receptor Adaptation
Chronic GABA flooding reshapes receptors; orexin blockade leaves them alone.
- 2–4 wk: Benzo tolerance onset (daily nightly use)
- moderate: Z-drug dependence risk (lower than benzos)
- minimal: Orexin antagonist dependence (no scheduled withdrawal signal)
- high: Benzo withdrawal severity (can include seizure risk)
GABA-A receptors downregulate with chronic use
Repeated flooding reduces receptor sensitivity, driving tolerance.
Withdrawal follows abrupt GABA-A adaptation
Stopping abruptly leaves neurons under-inhibited and hyperexcitable.
Orexin blockade does not remodel receptors
No chronic adaptation means little withdrawal signal on stopping.
What Is Left Over the Next Morning
Long-acting GABA drugs bleed into waking hours; orexin drugs clear faster.
- 20–100 h: Benzo half-life (long-acting) (e.g. diazepam class)
- ~12 h: Orexin antagonist half-life (daridorexant, typical)
- higher: Next-day driving impairment (with benzodiazepines)
- moderate: Z-drug morning hangover (dose- and agent-dependent)
Half-life drives residual sedation
Longer-acting GABA drugs still occupy receptors after waking.
Orexin blockade fades with the sleep window
Shorter effective action limits carryover sedation.
Dose and duration both matter
Higher doses and longer courses worsen next-day carryover.
Memory, Coordination, and Fall Risk
Broad GABA enhancement blunts memory and balance more than orexin blockade.
- higher: Anterograde amnesia risk (with benzodiazepines)
- elevated: Fall risk in older adults (GABAergic hypnotics)
- pronounced: Psychomotor slowing (benzo & Z-drug class)
- minimal: Orexin antagonist cognitive effect (at recommended doses)
GABA enhancement reaches memory circuits
Hippocampal GABA-A activation impairs new memory formation.
Cerebellar GABA-A slows coordination
Broad receptor coverage extends effects into balance and gait.
Orexin blockade spares these circuits
Localized action leaves memory and motor circuits largely untouched.
Weighing the Three-Way Safety Profile
Across dependence, sedation, and cognition, orexin antagonists score more favorably.
- high: Orexin antagonist safety score (composite estimate)
- moderate: Z-drug safety score (better than benzos)
- lower: Benzodiazepine safety score (composite estimate)
- key driver: Mechanism breadth (of the safety gap)
Dependence potential favors orexin blockade
Minimal receptor remodeling means minimal withdrawal risk.
Morning sedation favors orexin blockade
Shorter, targeted action limits next-day carryover.
Cognitive sparing favors orexin blockade
Localized circuits leave memory and coordination largely intact.